ECASS III - European Cooperative Acute Stroke Study III: A Placebo Controlled Trial of Alteplase (Rt-PA) in Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4 Hours 30 Minutes After Stroke Onset

Trial Profile

ECASS III - European Cooperative Acute Stroke Study III: A Placebo Controlled Trial of Alteplase (Rt-PA) in Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4 Hours 30 Minutes After Stroke Onset

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jan 2017

At a glance

  • Drugs Alteplase (Primary)
  • Indications Stroke
  • Focus Registrational; Therapeutic Use
  • Acronyms ECASSIII
  • Sponsors Boehringer Ingelheim Pharmaceuticals
  • Most Recent Events

    • 25 Sep 2008 Results presented at World Stroke Congress in Vienna.
    • 24 Sep 2008 Primary endpoint 'Modified Rankin scale score of 0 or 1' has been met.
    • 24 Sep 2008 Results have been published in the New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top